[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Heise T, De Vries JH, Coskun T, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Dunn JP, Haupt A, et al
Evoke and Evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimers disease
Figure 25: Photograph of Professor Daniel Drucker, credit Endocrine News
Researchers documented the amount of alcohol consumed
Others are technically long-term but come with monitoring requirements, side effects, stopping rules or limits on how much weight patients could expect to lose
This lets them watch for additive nausea, time the start of each medication sensibly, and confirm there are no other considerations specific to your health